Dynavax Technologies Q2 Loss Wider than Expected, Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 3:22PM CDT
Dynavax Technologies Corporation (DVAX) reported a loss of 9 cents per share in the second quarter of 2014, flat with the year-ago quarter but wider than the Zacks Consensus Estimate of a loss of 6 cents.
Theravance (THRX) Incurs Narrower-than-Expected Loss in Q2 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 8:10AM CDT
Theravance (THRX) incurred a loss of 18 cents in the quarter.
Kindred Healthcare (KND) in Focus: Stock Tumbles 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Aug 08, 7:31AM CDT
Kindred Healthcare has been witnessing flat earnings estimate revision, with its share price falling substantially for last few weeks
The Medicines Company's Orbactiv Approved on Solid SOLO Data - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 5:10PM CDT
Great news came in The Medicines Company's (MDCO) way when the FDA approved the company's antibiotic Orbactiv.
InterMune Q2 Loss Wider than Expected, Expense Guidance Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 1:50PM CDT
InterMune Inc.'s (ITMN) second-quarter 2014 loss of 67 cents was narrower than the year-ago loss of 78 cents.
Integra LifeSciences Tops Q2 Earnings, Revenues, Shares Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 11:00AM CDT
Following the earnings release, Integra LifeSciences' (IART) share price rose 1% to eventually close at $48.60 yesterday.
Ligand Gains on Q2 Earnings Beat, Increases Guidance - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 10:32AM CDT
Ligand Pharmaceuticals reported better-than-expected second quarter 2014 results and raised its guidance.
Discovery Laboratories Inc. (DSCO) in Focus: Stock Up 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Aug 07, 7:44AM CDT
Discovery Laboratories Inc. (DSCO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Sunesis Pharmaceuticals, Inc. (SNSS) Jumps: Stock Rises 9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 06, 8:32AM CDT
Sunesis Pharmaceuticals, Inc. (SNSS) was a big mover last session, as the company saw its shares rise more than 9% on the day.
Tekmira Pharma in Focus as the World Awaits Ebola Treatment - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 5:34PM CDT
Tekmira (TKMR) is in focus following Ebola outbreak.
Amgen's Multiple Myeloma Drug Kyprolis Succeeds - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 05, 5:21PM CDT
Amgen (AMGN) intends to submit regulatory applications based on this study in the first half of 2015.
Vertex Pharmaceuticals' Kalydeco Label Expanded in EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 5:05PM CDT
Vertex Pharmaceuticals Inc.'s (VRTX) cystic fibrosis (CF) drug Kalydeco received approval in the EU for eight additional gating mutations.
AbbVie's ABT-414 Receives Orphan Drug Status in U.S. and EU - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 4:50PM CDT
AbbVie's (ABBV) oncology candidate ABT-414 received orphan drug status in the U.S. and the EU for glioblastoma multiforme.
Regeneron Misses on Earnings in Q2, Eylea Drives Sales Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 2:02PM CDT
Regeneron (REGN) recorded higher than expected revenues due to strong Eylea sales.
Zoetis Misses Marginally on Q2 Earnings, Up Y/Y, View Adjusted - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 2:00PM CDT
Zoetis (ZTS) missed the Zacks Consensus Estimate by a penny.
Actavis Beats on Q2 Earnings & Revs, Provides 2015 Outlook - Analyst Blog
Arpita Dutt - Zacks Investment Research - Tue Aug 05, 1:00PM CDT
Actavis (ACT) second quarter results were boosted by the inclusion of products from the Warner Chilcott acquisition.
Ligand Pharmaceuticals (LGND) Jumps: Stock Up 10.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 8:25AM CDT
Ligand Pharmaceuticals (LGND) was a big mover last session, with shares rising over 10% on the day.
ANI Pharmaceuticals (ANIP) in Focus: Stock Surges 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Aug 05, 7:44AM CDT
ANI Pharmaceuticals, Inc. (ANIP) was a big mover last session, as the company saw its shares surge 11% on the day.
Seattle Genetics Up on Narrower-than-Expected Q2 Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 3:20PM CDT
Seattle Genetics reported second-quarter loss per share of 14 cents, narrower than the Zacks Consensus Estimate of a loss of 22 cents.
Alkermes Reports Loss in Q2 on Higher Costs, Revenues Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Aug 04, 2:40PM CDT
Alkermes (ALKS) incurred loss in the quarter due to higher expenses.